series-a
Stage
1
Investors
About
Myrobalan Therapeutics develops oral small molecule therapies targeting neuroinflammation and demyelination to treat central nervous system diseases such as multiple sclerosis, Alzheimer's, ALS, and Parkinson's disease.
Explore Myrobalan Therapeutics's full profile on Brouky
Funding rounds, investor list, and risk signals — unlock with a subscription.